Global Onychomycosis (Tinea Unguium) Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Onychomycosis (Tinea Unguium) Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.

Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

According to our (Global Info Research) latest study, the global Onychomycosis (Tinea Unguium) Drug market size was valued at US$ 3596 million in 2023 and is forecast to a readjusted size of USD 5266 million by 2030 with a CAGR of 5.7% during review period.

Global Onychomycosis (Tinea Unguium) Drug key players include Pfizer, J&J, Novartis, Galderma pharm, Valeant Pharma, etc. Global top five manufacturers hold a share about 35%.

North America is the largest market, with a share about 30%, followed by Europe and China both have a share over 45 percent.

In terms of product, Oral Medication is the largest segment, with a share over 70%. And in terms of application, the largest application is Age above 50, followed by Age under 18.

This report is a detailed and comprehensive analysis for global Onychomycosis (Tinea Unguium) Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Onychomycosis (Tinea Unguium) Drug market size and forecasts, in consumption value ($ Million), 2019-2030

Global Onychomycosis (Tinea Unguium) Drug market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Onychomycosis (Tinea Unguium) Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Onychomycosis (Tinea Unguium) Drug market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Onychomycosis (Tinea Unguium) Drug

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Onychomycosis (Tinea Unguium) Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Yangtze River, Torrent Pharma, J&J, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical, Hubei Hengan, TARO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Onychomycosis (Tinea Unguium) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Onychomycosis (Tinea Unguium) Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Oral Medication
External Medicine

Market segment by Application
Age under 18
Age 18-50
Age above 50

Market segment by players, this report covers
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Onychomycosis (Tinea Unguium) Drug, with revenue, gross margin, and global market share of Onychomycosis (Tinea Unguium) Drug from 2019 to 2024.

Chapter 3, the Onychomycosis (Tinea Unguium) Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Onychomycosis (Tinea Unguium) Drug market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Onychomycosis (Tinea Unguium) Drug.

Chapter 13, to describe Onychomycosis (Tinea Unguium) Drug research findings and conclusion.